Pemphigoid is a group of bullous diseases that have a diversified morpholog
ic presentation and affect the skin, oral mucosal and other mucosal membran
es, alone or in combination. In the literature, the condition has been subc
lassified into bullous pemphigoid and cicatricial pemphigoid (mucous membra
ne pemphigoid) on the basis of the primary organ of involvement. In additio
n to the clinical presentation and a subepithelial vesicle or bullae on rou
tine histologic analysis, the diagnosis is based on direct and indirect imm
unofluorescence studies. Recent investigations indicate that different clin
ical groups of patients with pemphigoid produce autoantibodies to different
molecules within the basement membrane zone. Based on these recent observa
tions and a review of the literature, a viewpoint is presented that not ail
patients with cicatricial pemphigoid should be grouped together. Rather, t
hey should be classified into subgroups-ocular, oral, etc-on the basis of t
he clinical phenotype and long-term follow-up. Such a division will facilit
ate the provision of appropriate and relevant treatment plans; if the clini
cal course changes, the diagnosis can be adjusted. This strategy will preve
nt patients with disease limited to the oral cavity from receiving systemic
drugs or agents that may be more harmful than beneficial.